PFIZER INC Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31)
PFIZER INC (PFE) reported Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) of $14.68 billion for the 87-month period ending 2012-04-01, per its 10-Q filed 2012-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostCostIncurredToDate · last filed 2012-05-10
- PFIZER INC restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2011-04-03 was $655.00M.
- PFIZER INC restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2010-12-31 was $759.00M.
- PFIZER INC restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2010-10-03 was $268.00M.
- PFIZER INC restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2010-07-04 was $671.00M, a 285.63% increase year-over-year.
| Period end | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 3 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 6 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 9 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 12 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 66 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 69 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 72 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 75 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 78 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 81 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 84 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 87 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-04-01 | $14.68B 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $14.19B 10-K · filed 2012-02-28 | |||||||||||
| 2011-10-02 | $13.90B 10-Q · filed 2011-11-10 | |||||||||||
| 2011-07-03 | $12.99B 10-Q · filed 2011-08-11 | |||||||||||
| 2011-04-03 | $655.00M derived: 10-Q 75 month − 10-K 72 month · filed 2011-05-12 | $1.41B derived: sum of 2 quarters · filed 2011-05-12 | $1.68B derived: sum of 3 quarters · filed 2011-05-12 | $2.35B derived: sum of 4 quarters · filed 2011-05-12 | $12.72B 10-Q · filed 2011-05-12 | |||||||
| 2010-12-31 | $759.00M derived: 10-K 72 month − 10-Q 69 month · filed 2011-02-28 | $1.03B derived: sum of 2 quarters · filed 2011-02-28 | $1.70B derived: sum of 3 quarters · filed 2011-02-28 | $12.07B 10-K · filed 2011-02-28 | ||||||||
| 2010-10-03 | $268.00M derived: 10-Q 69 month − 10-Q 66 month · filed 2010-11-12 | $939.00M derived: sum of 2 quarters · filed 2010-11-12 | $11.31B 10-Q · filed 2010-11-12 | |||||||||
| 2010-07-04 | $671.00M 10-Q · filed 2010-08-12 | $1.16B 10-Q · filed 2010-08-12 | $11.04B 10-Q · filed 2010-08-12 | |||||||||
| 2009-06-28 | $174.00M 10-Q · filed 2010-08-12 | $331.00M 10-Q · filed 2010-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |